Indaptus Therapeutics Inc (INDP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

12 HARTOM STREET JERUSALEM, ISRAEL 777512

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

Data as of 2021-10-09 10:20:20 -0400
Market Cap41.518 Million Shares Outstanding5.406 Million Avg 30-day Volume11.791 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.65 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.7836 52-week High/Low36.8 / 6.83 Next Earnings Date2021-11-08 Price to Cash FLow (P/CF) -9.8279
Data provided by IEX Cloud
View SEC Filings from INDP instead.

View recent insider trading info

Funds Holding INDP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INDP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

12 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MECKLER JEFFREY A CEO AND DIRECTOR

  • Officer
  • Director
14,460 2021-09-14 2

HAYES WILLIAM B

  • Director
13,750 2021-08-04 1

O'CALLAGHAN BRIAN

  • Director
13,750 2021-08-04 2

MADDALUNA ANTHONY J

  • Director
13,750 2021-08-04 1

POMERANTZ ROGER

  • Director
41,000 2021-08-04 1

LINSCOTT WALT ADDISON CHIEF BUSINESS OFFICER

  • Officer
210,000 2021-08-04 1

KARAH HILA

  • Director
13,750 2021-08-04 1

SASSI NIR CHIEF FINANCIAL OFFICER

  • Officer
35,000 2021-08-04 1

LEE HOONMO

  • Director
13,750 2021-08-04 2

NEWMAN MICHAEL JAMES CSO AND DIRECTOR

  • Officer
  • Director
  • 10% Owner
290,000 2021-08-04 2

NAVON NADAV CHIEF OPERATING OFFICER

  • Officer
0 2020-09-16 0

KOZARICH JOHN W

  • Director
0 2020-07-15 0

GENDREAU R MICHAEL CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-17 0

DEXCEL PHARMA TECHNOLOGIES LTD.

OREN DAN

  • 10% Owner
No longer subject to file 2020-01-31 0

SILBERMAN ISSAC

  • Director
4,000 2019-11-19 0

BIANCO GIL

  • Director
0 2019-06-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MECKLER JEFFREY A - Director - Officer CEO AND DIRECTOR

2021-09-16 18:22:00 -0400 2021-09-14 P 12,000 $7.00 a 14,460 direct -13.1944 -12.5 0.0 1 -17.9563 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 22:15:04 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 21:45:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 21:15:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 20:45:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 20:15:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 19:45:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 19:15:04 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 18:45:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 18:15:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 17:45:03 UTC -76.5568 76.6268 150000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 17:15:03 UTC -76.5568 76.6268 40000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 16:45:03 UTC -76.5568 76.6268 40000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 16:15:03 UTC -76.5568 76.6268 40000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 15:45:03 UTC -76.5568 76.6268 40000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 15:15:03 UTC -76.5568 76.6268 30000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 14:45:02 UTC -89.1989 89.2689 30000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 14:15:03 UTC -89.1989 89.2689 30000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 13:45:03 UTC -89.1989 89.2689 30000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 13:15:03 UTC -89.1989 89.2689 30000
INDAPTUS THERAPEUTICS INC INDP 2021-10-15 12:45:03 UTC -89.1989 89.2689 65000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments